title: Cyclodialysis cleft after intravitreal injection of ranibzumab - diagnosis and management.
authors.affiliation: Department of Ophthalmology, Cantonal Hospital of Lucerne, Lucerne, Switzerland (Director Prof. Dr. Dr. Michael A. Thiel).
authors.forename: S C
authors.initials: SC
authors.lastname: Böhni
authors.affiliation: Department of Ophthalmology, Cantonal Hospital of Lucerne, Lucerne, Switzerland (Director Prof. Dr. Dr. Michael A. Thiel).
authors.forename: J P
authors.initials: JP
authors.lastname: Howell
authors.affiliation: Department of Ophthalmology, Cantonal Hospital of Lucerne, Lucerne, Switzerland (Director Prof. Dr. Dr. Michael A. Thiel).
authors.forename: M K
authors.initials: MK
authors.lastname: Schmid
authors.affiliation: Department of Ophthalmology, Cantonal Hospital of Lucerne, Lucerne, Switzerland (Director Prof. Dr. Dr. Michael A. Thiel).
authors.forename: F
authors.initials: F
authors.lastname: Bochmann
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D020256:Choroidal Neovascularization / Q000150:complications / Q000188:drug therapy; D002924:Ciliary Body / Q000293:injuries* / Q000473:pathology / Q000601:surgery; D015807:Eye Injuries, Penetrating / Q000473:pathology / Q000601:surgery*; D005260:Female; D006801:Humans; D058449:Intravitreal Injections / Q000009:adverse effects*; D008875:Middle Aged; D000069579:Ranibizumab / Q000008:administration & dosage* / Q000009:adverse effects*; D013536:Suture Techniques; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D020533:Angiogenesis Inhibitors; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000069579:Ranibizumab